Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (288)
- COVID-19 (164)
- Safety monitoring and information (112)
- Compliance and enforcement (85)
- Legislation (77)
- Manufacturing (59)
- Vaping hub (56)
- Labelling and packaging (41)
- Import and export (35)
- Medicinal cannabis hub (27)
- Scheduling (national classification system) (27)
- Sunscreens (20)
- Weight loss products (18)
- Shortages and supply disruptions (11)
- Committees and advisory bodies (9)
- Cosmetics (6)
- Unique Device Identification (UDI) hub (5)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1273 result(s) found, displaying 1151 to 1175
-
BlogWhat is the TGA? Learn why and how we regulate medicines and medical devices.
-
Media releasesJoint media release between Australian Border Force and Therapeutic Goods Administration
-
BlogSome retailers try to use disclaimers like 'for research purposes only' to sell an illegal product, but these disclaimers don't change the law.
-
Safety updatesCase studies in Incident Report Investigations; review of reusable biopsy forceps devices; care required with patient lifters
-
Media releasesThe TGA has launched a web hub to help consumers and health professionals find information on transvaginal (urogynaecological) surgical mesh.
-
Safety updatesNew warning labels for neuromuscular blocking agents; local anaesthetic systemic toxicity; off-label use of atropine
-
BlogGeorgia's story explains how to spot the warning signs for the breast implant associated cancer BIA-ALCL.
-
Regulatory decision noticesTGA issues advertising direction
-
Media releasesToday we celebrate the official launch of the TGA Facebook page
-
Safety updatesThe TGA completed a desktop review of selected listed sunscreen products.
-
Safety updatesBe aware of cross-reactivity with home-use self-test ovulation kits, TGA undertakes product safety review into intragastric balloon systems
-
Media releasesOur annual survey measures satisfaction with a range of services and activities including our role and performance
-
Media releasesApalutamide (Erlyand) is the first medicine approved via ACSS Consortium’s NCE working group
-
Media releasesConsumers can now report dodgy ads for medicines and medical devices through a single online form
-
Safety updatesOral methotrexate dosing, medicines associated with a risk of neuropsychiatric adverse events, and clozapine and gastrointestinal effects
-
BlogCaitlin's story explains how a patient in Australia can legally access medicinal cannabis.
-
News articlesList of OTC codeine-containing products moving to prescription only
-
Regulatory decision noticesThis instrument applies to an application to list a complementary medicine under section 26AE of the Act.
-
Regulatory decision noticesThis instrument applies to an application to list a medicine under section 26 or 26A of the Act.
-
Regulatory decision noticesThis instrument applies to an application to register a complementary medicine
-
Safety updatesHow TGA uses joint replacement registry data; Focus on skills for vacuum-assisted births; TGA reviews product safety of ventilators
-
Regulatory decision noticesThis instrument applies to the online form titled Prescription Medicines Designation/Determination Application in the TGA's electronic lodgement facility, completed in accordance with the relevant instructions in that form.
-
Regulatory decision noticesTherapeutic Goods (Provisional Determinations and Orphan Drug Designations-Extension) Approval of Application Form.
-
Media releasesInformation about influenza vaccines for use in 2018
-
Media releasesIn reference to the ABC’s Fact Check article “Will the move to make codeine prescription-only save a100 lives a year” the Therapeutic Goods Administration (TGA) would like to clarify: